Obsessive-Compulsive Disorder Clinical Trial
Official title:
Behavior Therapy for Childhood OCD
The purpose of this study is to evaluate a behavioral treatment program for children and
adolescents with OCD and their families. Exposure and Response Prevention (ERP) behavior
therapy, in which the patient is gradually exposed to the object or situation that causes
anxiety and is taught to refrain from responding in a compulsive manner, is combined with
family counseling (Family Treatment Program). This treatment will be compared to Relaxation
Training (RT).
OCD is a long-term, often disabling disorder that can cause significant family disruption.
ERP is a promising treatment for children with OCD, and it is thought that family
participation (through the Family Treatment Program) may be a helpful addition. RT is a
common treatment for anxiety.
Patients are assigned randomly (like tossing a coin) to receive either the ERP/Family
Treatment Program or RT. Both treatments will be delivered over 12 90-minute outpatient
sessions to youngsters and their families. All participants (patients and family members)
will be assessed for treatment response each month during treatment, after treatment is
finished, and then at 2 follow-up visits over the following 6 months.
A child/adolescent may be eligible for this study if he/she:
Has obsessive-compulsive disorder (OCD), is medication-free, and is 8 to 17 years old.
Status | Completed |
Enrollment | 0 |
Est. completion date | November 2003 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 8 Years to 17 Years |
Eligibility |
Inclusion Criteria: Patients must have: Obsessive-compulsive disorder for which he/she has not received medication. |
Allocation: Randomized, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Univ. of California / Los Angeles / Neuropsychiatric Inst. | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
National Institute of Mental Health (NIMH) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |